Skip to Content
Merck
CN

R5257

Spe I from Sphaerotilus sp.

Restriction Enzyme

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

CAS Number:
UNSPSC Code:
12352204
MDL number:
EC Number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


grade

Molecular Biology

form

buffered aqueous glycerol solution

concentration

10,000 units/mL

shipped in

wet ice

storage temp.

−20°C

Application

SpeI is a restriction endonuclease used for molecular biology applications to cut DNA at the recognition site 5′-A/CTAGT-3′, generating DNA fragments with 5′-cohesive ends.

Biochem/physiol Actions

Recognition sequence: 5′-A/CTAGT-3′
Cutting results: a 2-10-fold Spe I overdigestion of 1 μg λ DNA substrate results in 100% cutting.
Heat inactivation: Inactivated at 65 °C for 20 minutes.

Physical form

Solution in 20 mM Tris-HCl, pH 8.0 , 0.1 mM EDTA, 100 mM NaCl, 10 mM 2-mercaptoethanol, 50% glycerol (v/v), 0.2% Triton X-100 (v/v), at 4 °C

Other Notes

Supplied with 10x Restriction Enzyme Buffer SH (B3657).


Storage Class

13 - Non Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Sorting out tigers (Panthera tigris: mitochondrial sequences, nuclear inserts, systematics, and conservation genetics.
Cracraft, J., et al.
Animal Conservation, 1, 139-139 (1998)
Restriction and modification enzymes and their recognition sequences.
R J Roberts
Nucleic acids research, 13 Suppl, r165-r200 (1985-01-01)
Gianluigi Lombardi et al.
Journal of clinical microbiology, 40(11), 4051-4055 (2002-11-01)
Successful carbapenem-based chemotherapy for the treatment of Pseudomonas infections has been seriously hindered by the recent appearance of IMP- and VIM-type metallo-beta-lactamases, which confer high-level resistance to carbapenems and most other beta-lactams. Recently, multidrug-resistant Pseudomonas putida isolates for which carbapenem